Author

Hayley S. Ramshaw

Monash UniversityORCID 0000-0001-9909-282XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:clinical cohort / trial· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Anton Yariv PelegiD· 1 shared Bradley J. GardineriD· 1 shared C. Rees· 1 shared D. KeatingiD· 1 shared Denis KorneeviD· 1 shared Devang M. PateliD· 1 shared Dinesh SubediiD· 1 shared Fernando L. Gordillo AltamiranoiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Anton Yariv PelegORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Mechanistic insights and clinical implications of cross-reactive anti-prophage antibodies and bacterial heteroresistance on phage therapeutic failure

Fernando L. Gordillo Altamirano, Dinesh Subedi, Mariel Beiers, Michael J Bucher, Sofia Dahlman, Devang M. Patel, M. Parker, Denis Korneev, Marcus J Robinson, Katherine Pragastis, J. Wisniewski, C. Rees, Hayley S. Ramshaw, Sadid F Khan, Bradley J. Gardiner, , Anton Yariv Peleg

The paper identifies pre-existing anti-prophage antibodies and bacterial heteroresistance as factors contributing to phage therapy failure in a patient with chronic infection.

Nature Medicine · Apr 24, 2026Peer-reviewedMicrobiology